IRIS
MONDA, EMANUELE
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 6.559
NA - Nord America 3.686
AS - Asia 3.365
SA - Sud America 486
Continente sconosciuto - Info sul continente non disponibili 258
AF - Africa 53
OC - Oceania 9
Totale 14.416
Salva come PNG Salva come JPEG
Nazione #
RU - Federazione Russa 4.906
US - Stati Uniti d'America 3.580
SG - Singapore 1.208
IT - Italia 735
CN - Cina 698
VN - Vietnam 520
HK - Hong Kong 446
BR - Brasile 396
IE - Irlanda 368
DE - Germania 169
KR - Corea 163
IN - India 133
GB - Regno Unito 117
CA - Canada 51
JP - Giappone 39
AR - Argentina 37
BD - Bangladesh 37
FR - Francia 36
FI - Finlandia 33
AT - Austria 30
MX - Messico 29
GR - Grecia 23
SE - Svezia 22
NL - Olanda 20
EC - Ecuador 19
ZA - Sudafrica 18
TR - Turchia 16
UA - Ucraina 16
CH - Svizzera 14
IQ - Iraq 13
MA - Marocco 11
PK - Pakistan 11
PL - Polonia 11
CO - Colombia 10
EE - Estonia 9
ES - Italia 9
ID - Indonesia 9
IR - Iran 9
LT - Lituania 8
SA - Arabia Saudita 8
CZ - Repubblica Ceca 7
NZ - Nuova Zelanda 7
PH - Filippine 7
VE - Venezuela 7
CR - Costa Rica 6
EG - Egitto 6
IL - Israele 6
JM - Giamaica 6
JO - Giordania 5
NP - Nepal 5
UZ - Uzbekistan 5
CL - Cile 4
KZ - Kazakistan 4
PE - Perù 4
PT - Portogallo 4
UY - Uruguay 4
AE - Emirati Arabi Uniti 3
BE - Belgio 3
BG - Bulgaria 3
DZ - Algeria 3
ET - Etiopia 3
PY - Paraguay 3
SN - Senegal 3
TW - Taiwan 3
AU - Australia 2
AZ - Azerbaigian 2
HN - Honduras 2
HU - Ungheria 2
KE - Kenya 2
KG - Kirghizistan 2
LB - Libano 2
LK - Sri Lanka 2
MT - Malta 2
MY - Malesia 2
OM - Oman 2
PA - Panama 2
PR - Porto Rico 2
RO - Romania 2
RS - Serbia 2
SK - Slovacchia (Repubblica Slovacca) 2
SV - El Salvador 2
TH - Thailandia 2
TN - Tunisia 2
TT - Trinidad e Tobago 2
AG - Antigua e Barbuda 1
AL - Albania 1
BB - Barbados 1
BF - Burkina Faso 1
BS - Bahamas 1
BW - Botswana 1
CG - Congo 1
CY - Cipro 1
DK - Danimarca 1
GH - Ghana 1
GT - Guatemala 1
GY - Guiana 1
LU - Lussemburgo 1
LV - Lettonia 1
MD - Moldavia 1
NO - Norvegia 1
Totale 14.154
Salva come PNG Salva come JPEG
Città #
Moscow 1.833
San Jose 576
Singapore 526
Santa Clara 467
Hong Kong 432
Ashburn 381
Dublin 368
Council Bluffs 312
Chandler 189
Ho Chi Minh City 178
Hefei 173
Seoul 162
Hanoi 130
New York 117
Milan 110
Naples 95
Beijing 79
Bengaluru 67
Los Angeles 62
Princeton 50
Roxbury 49
The Dalles 49
Rome 48
Munich 47
North Bergen 43
Dallas 42
Bremen 41
Cambridge 31
Da Nang 29
São Paulo 29
Kochi 25
Miano 24
Atlanta 23
Aversa 22
Frankfurt am Main 22
Haiphong 22
Phoenix 22
Jacksonville 20
Napoli 20
Nuremberg 20
Falkenstein 18
Medford 18
Turin 18
Turku 18
Brooklyn 17
Chicago 17
Marano Di Napoli 17
Des Moines 16
Orem 16
Vienna 16
Biên Hòa 14
Brasília 14
Toronto 14
Amsterdam 13
Caserta 13
Hyderabad 12
London 12
Chennai 11
Dhaka 11
Guangzhou 11
Memphis 11
Tokyo 11
Boardman 10
Bologna 10
Denver 10
Rio de Janeiro 10
Wilmington 10
Belo Horizonte 9
Curitiba 9
Johannesburg 9
Montreal 9
Salvador 9
San Giovanni In Fiore 9
Helsinki 8
Ninh Bình 8
San Francisco 8
Shanghai 8
Stockholm 8
Thái Nguyên 8
Baghdad 7
Bari 7
Casalnuovo di Napoli 7
Florence 7
Fortaleza 7
Guayaquil 7
Boston 6
Buenos Aires 6
Hải Dương 6
Lappeenranta 6
Mexico City 6
Nanjing 6
Palermo 6
Pozzuoli 6
Quito 6
San José 6
Seattle 6
Warsaw 6
Amman 5
Bắc Ninh 5
Cairo 5
Totale 7.534
Salva come PNG Salva come JPEG
Nome #
Bisoprolol for treatment of symptomatic patients with obstructive hypertrophic cardiomyopathy. The BASIC (bisoprolol AS therapy in hypertrophic cardiomyopathy) study 276
Diagnostic issues faced by a rare disease healthcare network during Covid-19 outbreak: data from the Campania Rare Disease Registry 219
The Risk of Sudden Unexpected Cardiac Death in Children: Epidemiology, Clinical Causes, and Prevention 198
Advanced Heart Failure in Special Population—Pediatric Age 187
Combined Effect of Mediterranean Diet and Aerobic Exercise on Weight Loss and Clinical Status in Obese Symptomatic Patients with Hypertrophic Cardiomyopathy 176
Cardiovascular Involvement in mtDNA Disease: Diagnosis, Management, and Therapeutic Options 173
Multimodality Imaging in Cardiomyopathies with Hypertrophic Phenotypes 172
Role of the orexin system on arousal, attention, feeding behaviour and sleep disorders 171
Beyond cholesterol metabolism: The pleiotropic effects of proprotein convertase subtilisin/kexin type 9 (PCSK9). Genetics, mutations, expression, and perspective for long-term inhibition 171
Natural history of left ventricular hypertrophy in infants of diabetic mothers 171
Diagnosis and Management of Cardiovascular Involvement in Friedreich Ataxia 166
Aortopathies in mouse models of Pompe, Fabry and Mucopolysaccharidosis IIIB lysosomal storage diseases 164
Diagnosis and Management of Cardiovascular Involvement in Fabry Disease 163
Medical treatment of patients with hypertrophic cardiomyopathy: An overview of current and emerging therapy 162
Access-Site Crossover in Patients With Acute Coronary Syndrome Undergoing Invasive Management 160
Clinical, Genetic, and Histological Characterization of Patients with Rare Neuromuscular and Mitochondrial Diseases Presenting with Different Cardiomyopathy Phenotypes 155
The Heart Muscle and Valve Involvement in Marfan Syndrome, Loeys-Dietz Syndromes, and Collagenopathies 153
Combined Clinical, Molecular, and Muscle Biopsy Approach to Unveil Prevalence and Clinical Features of Rare Neuromuscular and Mitochondrial Diseases in Patients With Cardiomyopathies 152
Effect of beta-blockers and angiotensin receptor blockers in reducing the aortic growth rate in children with bicuspid aortic valve-related aortopathy 148
Natural History of Hypertrophic Cardiomyopathy in Noonan Syndrome With Multiple Lentigines 145
Cardiovascular Involvement in Transthyretin Cardiac Amyloidosis 145
Aortic Root Diameter in Highly-Trained Competitive Athletes: Reference Values According to Sport and Prevalence of Aortic Enlargement 143
Aetiology and clinical manifestations of patients with non-dilated left ventricular cardiomyopathy 143
Diagnosis and Management of Rare Cardiomyopathies in Adult and Paediatric Patients. A Position Paper of the Italian Society of Cardiology (SIC) and Italian Society of Paediatric Cardiology (SICP) 143
Pathophysiology, Functional Assessment and Prognostic Implications of Nutritional Disorders in Systemic Amyloidosis 141
The Role of Genetic Testing in Patients with Heritable Thoracic Aortic Diseases 140
An atypical Aymé-Gripp phenotype detected by exome sequencing 140
Low-Dose Ticagrelor in Patients With High Ischemic Risk and Previous Myocardial Infarction: A Multicenter Prospective Real-World Observational Study 140
Prevalence and clinical significance of right ventricular pulmonary arterial uncoupling in cardiac amyloidosis 138
Multimodality Imaging in Arrhythmogenic Left Ventricular Cardiomyopathy 137
Immune-Checkpoint Inhibitor-Related Myocarditis: Where We Are and Where We Will Go 135
Multidisciplinary In-Depth Investigation in a Young Athlete Suffering from Syncope Caused by Myocardial Bridge 135
Clinical Manifestations of 22q11.2 Deletion Syndrome 132
Patterns of Left Ventricular Remodelling in Children and Young Patients with Hypertrophic Cardiomyopathy 131
A complex unit for a complex disease: The HCM-Family Unit 129
Cardiovascular Involvement in Fabry's Disease: New Advances in Diagnostic Strategies, Outcome Prediction and Management 129
Global left ventricular myocardial work efficiency in heart failure patients with cardiac amyloidosis: Pathophysiological implications and role in differential diagnosis 129
Impact of GLA Variant Classification on the Estimated Prevalence of Fabry Disease: A Systematic Review and Meta-Analysis of Screening Studies 128
Prevalence and Clinical Significance of Intraventricular Conduction Disturbances in Hospitalized Children 127
Resistive index of central retinal artery, aortic arterial stiffness and OCTA correlated parameters in the early stage of fabry disease 124
External validation of the increased wall thickness score for the diagnosis of cardiac amyloidosis 124
SYNERGISM OR COMPETITION BETWEEN ZINC AND CHROMIUM DIETARY LEVELS ON INSULIN ACTION MECHANISM. A METHOD TO INVESTIGATE 123
Artificial intelligence for left ventricular hypertrophy detection and differentiation on echocardiography, cardiac magnetic resonance and cardiac computed tomography: A systematic review 123
The Role of Echocardiography for the Clinical Diagnosis, Risk Stratification, and Management of Cardiac Amyloidosis 121
Effectiveness in the short-term of a novel nutraceutical for the management of hypercholesterolemia: an observational multicenter primary care experience 121
Genotype-Phenotype Correlations in ATTR Amyloidosis: A Clinical Update 120
Targeted Therapies in Pediatric and Adult Patients With Hypertrophic Heart Disease: From Molecular Pathophysiology to Personalized Medicine 120
[Rare Diseases and epidemiology: an overlook at data from the Campania Region Rare Disease Registry (Southern Italy)] 119
Left Ventricular Non-Compaction in Children: Aetiology and Diagnostic Criteria 117
Amyloid Cardiomyopathies: Clinical, Diagnostic, and Therapeutic Aspects 117
Hypertrophic Cardiomyopathy in RASopathies: Diagnosis, Clinical Characteristics, Prognostic Implications, and Management 117
Prevalence and direct costs of patients with neuromyelitis optica: Data from Campania region in southern Italy 116
Severe Lymphatic Disorder and Multifocal Atrial Tachycardia Treated with Trametinib in a Patient with Noonan Syndrome and SOS1 Mutation 115
Yield and clinical significance of genetic screening in elite and amateur athletes 115
Thoracic Aortic Dilation: Implications for Physical Activity and Sport Participation 113
Prevalence and clinical significance of red flags in patients with hypertrophic cardiomyopathy 113
Clinical characteristics and outcome of end stage hypertrophic cardiomyopathy: Role of age and heart failure phenotypes 111
Diagnosis of Fabry Disease in a Patient with a Surgically Repaired Congenital Heart Defect: When Clinical History and Genetics Make the Difference 111
Beta-blockers in heart failure prognosis: Lessons learned by MECKI Score Group papers 109
Treatment options for hypertrophic obstructive cardiomyopathy: a patient-centric review 108
Lipoprotein(a): a genetic marker for cardiovascular disease and target for emerging therapies 108
Clinical pathway on pediatric cardiomyopathies: A genetic testing strategy proposed by the Italian Society of Pediatric Cardiology 107
Athlete’s Heart: A Cardiovascular Step-By-Step Multimodality Approach 107
The Role of New Imaging Technologies in the Diagnosis of Cardiac Amyloidosis 107
ECG analysis in patients with acute coronary syndrome undergoing invasive management: rationale and design of the electrocardiography sub-study of the MATRIX trial 105
Hypertrophic cardiomyopathy: prevalence of disease-specific red flags 103
Prevalence of Pathogenic Variants in Cardiomyopathy-Associated Genes in Acute Myocarditis 102
Prediction of incident atrial fibrillation in hypertrophic cardiomyopathy 101
Orexin system: Network multi-tasking 100
Unexplained sudden cardiac arrest in children: clinical and genetic characteristics of survivors 100
An Overview of Molecular Mechanisms in Fabry Disease 100
The role of genetic testing in Marfan syndrome 100
Potential role of imaging markers in predicting future disease expression of arrhythmogenic cardiomyopathy 99
Current Management of Transition and Multidisciplinary Care of Patients with Inherited and Rare Cardiomyopathies in Europe: Results of the European Reference Network for Rare and Low Prevalence Complex Diseases of the Heart (ERN GUARD-HEART) 98
Clinical manifestation of patients with Fabry disease and R356W GLA variant 97
Hypertrophic Cardiomyopathy in Children: Pathophysiology, Diagnosis, and Treatment of Non-sarcomeric Causes 97
Sport activity in patients with cardiomyopathies: a review 96
A Roadmap to Predict Adverse Outcome in Fabry Disease 96
Rare Cardiovascular Diseases: From Genetics to Personalized Medicine 95
Molecular Basis of Inflammation in the Pathogenesis of Cardiomyopathies 93
Impact of Regular Physical Activity on Aortic Diameter Progression in Paediatric Patients with Bicuspid Aortic Valve 93
Clinical significance of family history and bicuspid aortic valve in children and young adult patients with Marfan syndrome 92
Genetic evaluation in athletes and cascade family screening: reply 92
Prognostic Implications of Declining Hemoglobin Content in Patients Hospitalized With Acute Coronary Syndromes 90
Sudden cardiac death risk prediction in Fabry disease: How many strings do we have on our bow? 88
Modified Body Mass Index as a Novel Nutritional and Prognostic Marker in Patients with Cardiac Amyloidosis 88
Left ventricular rotational mechanics in cardiac amyloidosis - reply 88
Prediction of radial crossover in acute coronary syndromes: Derivation and validation of the MATRIX score 88
Implantable cardioverter defibrillator in hypertrophic cardiomyopathy: Time to avoid unnecessary procedure 88
Naxos Disease and Related Cardio-Cutaneous Syndromes 87
Is There a Role for Genetic Testing in Patients With Myocarditis? 85
Editorial: Paediatric Cardiomyopathies 85
Hypertrophic Cardiomyopathy-Current Challenges and Future Perspectives 84
From the phenotype to precision medicine: an update on the cardiomyopathies diagnostic workflow 84
Prevalence and cardiovascular outcomes of left ventricular hypertrabeculation in children 84
Real-world candidacy to mavacamten in a contemporary hypertrophic obstructive cardiomyopathy population 84
The Prognostic Role of Pulmonary Arterial Elastance in Patients Undergoing Left Ventricular Assist Device Implantation: A Pilot Study 82
Cardiovascular Morbidity and Mortality in Fabry Disease 82
Prevalence and clinical implications of hyperhomocysteinaemia in patients with hypertrophic cardiomyopathy and MTHFR C6777T polymorphism 82
Rare case of Kawasaki disease with cardiac tamponade and giant coronary artery aneurysms 82
Totale 12.263
Salva come PNG Salva come JPEG
Categoria #
all - tutte 48.975
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 48.975
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022325 0 0 0 18 91 12 11 28 9 25 21 110
2022/2023703 76 54 8 38 82 36 4 42 324 5 19 15
2023/2024487 20 13 13 29 106 112 13 42 9 12 24 94
2024/20251.958 8 12 4 39 332 268 237 179 309 230 195 145
2025/20269.016 450 511 432 347 699 4.608 616 438 344 263 181 127
2026/20271.711 66 307 693 645 0 0 0 0 0 0 0 0
Totale 14.416